Viridian Therapeutics Inc (NASDAQ:VRDN)

Delayed Data
As of Oct 27
 +0.41 / +2.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Viridian Therapeutics Inc have a median target of 38.00, with a high estimate of 44.00 and a low estimate of 28.00. The median estimate represents a +112.17% increase from the last price of 17.91.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Viridian Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 43.29%
Growthannually 82.74%


Growthquarterly -58.33%
Growthannually 224.13%
Key to the earnings and sales forecast charts.